Basic Information
Basic information for LINC01010-201-41aa-2
Peptide Name LINC01010-201-41aa-2
Genome Position chr6:134503415-134503537[+]
Species Human
Peptide Sequence MSRILLVPGKAVPSTTLQSFNKGLKDTTFPKVLTSLFAGNK
Peptide Length 41
Unique No (LINC01010-202-41aa-1,LINC01010-203-41aa-2,LINC01010-204-41aa-2,LINC01010-205-41aa-2,LINC01010-206-41aa-1,LINC01010-207-41aa-2,LINC01010-208-41aa-1,LINC01010-209-41aa-2,LINC01010-210-41aa-1,LINC01010-211-41aa-2,LINC01010-212-41aa-2,LINC01010-213-41aa-1,LINC01010-214-41aa-2,LINC01010-215-41aa-2,LINC01010-216-41aa-2)
Grand Average of Hydropathicity 0.0756
Relative Molecular Mass 5128
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000236700;LINC01010
Transcript ID/Name ENST00000431422;LINC01010-201
Transcript Length 2107
Coding Ability 0.514
DNA Sequence Corresponding to Peptide ATGAGTAGGATTCTGCTGGTGCCTGGGAAGGCAGTGCCATCTACAACTTTACAAAGTTTTAACAAAGGCCTGAAGGACACAACCTTCCCCAAAGTCCTGACGTCGCTGTTTGCTGGCAACAAA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :